India Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027
Summary
Pharmaceuticals in India industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
The Indian pharmaceuticals market had total revenues of $24.2 billion in 2022, representing a compound annual growth rate (CAGR) of 6.3% between 2017 and 2022.
0
The growth of the pharmaceutical market in recent years can be partly attributed to rising GDP, increased specialty drug innovation, and increasing access to medicines. For instance, the real GDP annual growth rate of India in 2022 stood at 7.2%, according to in-house research.
Scope
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in India
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in India
Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the India pharmaceuticals market with five year forecasts
Reasons to Buy
What was the size of the India pharmaceuticals market by value in 2022?
What will be the size of the India pharmaceuticals market in 2027?
What factors are affecting the strength of competition in the India pharmaceuticals market?
How has the market performed over the last five years?
What are the main segments that make up India's pharmaceuticals market?
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the most recent market developments?
8 Company Profiles
8.1. Sun Pharmaceutical Industries Ltd
8.2. Lupin Ltd
8.3. Dr. Reddy's Laboratories Limited
8.4. Aurobindo Pharma Ltd
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: India pharmaceuticals market value: $ billion, 2017-22
Table 2: India pharmaceuticals market geography segmentation: $ billion, 2022
Table 3: India pharmaceuticals market value forecast: $ billion, 2022-27
Table 4: Sun Pharmaceutical Industries Ltd: key facts
Table 5: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 6: Sun Pharmaceutical Industries Ltd: Key Employees
Table 7: Sun Pharmaceutical Industries Ltd: Key Employees Continued
Table 8: Lupin Ltd: key facts
Table 9: Lupin Ltd: Annual Financial Ratios
Table 10: Lupin Ltd: Key Employees
Table 11: Dr. Reddy's Laboratories Limited: key facts
Table 12: Dr. Reddy's Laboratories Limited: Annual Financial Ratios
Table 13: Dr. Reddy's Laboratories Limited: Key Employees